ROC-101

N/A

Report date: 2026/04/17 20:02:02
NMEFirst In Class

Base Information

Drug NameROC-101
Drug Alias NameROC-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 1 inhibitorsRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsLung Diseases, InterstitialPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllRock Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllRock Bio Inc
Inactive CompaniesN/A
Active IndicationsLung Diseases, InterstitialPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A